Engineering immunity: bacterial delivery of cancer neoantigen vaccines
Trends in Immunology · 2024
DOI: 10.1016/j.it.2024.11.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2024. Verfasst von Christopher D Johnston und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77006, USA. Hauptthemen laut MEDLINE: Cancer Vaccines, Antigens, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77006, USA.
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77006, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77006, USA. Elec…
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Johnston, C. D., & Wargo, J. A. (2024). Engineering immunity: bacterial delivery of cancer neoantigen vaccines. Trends in Immunology. https://doi.org/10.1016/j.it.2024.11.007
Vancouver
Johnston CD, Wargo JA. Engineering immunity: bacterial delivery of cancer neoantigen vaccines. Trends in Immunology. 2024. doi:10.1016/j.it.2024.11.007
BibTeX
@article{Johnston2024,
author = {Johnston, Christopher D and Wargo, Jennifer A},
title = {Engineering immunity: bacterial delivery of cancer neoantigen vaccines},
journal = {Trends in Immunology},
year = {2024},
doi = {10.1016/j.it.2024.11.007}
}
EUVIMED